Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Insulin-like growth factors (IGFs) are potent mitogens that bind with high affinity and specificity to IGF receptors and IGF-binding proteins (IGFBPs). We studied the roles of these three groups of proteins in prostate epithelial cells (PEC) in primary culture grown under serum-free conditions. Affinity cross-linking of IGF-I and IGF-II to crude membranes prepared from PEC revealed an abundance of type 1 IGF receptors and no evidence of type 2 IGF receptors. Western ligand blots of conditioned media (CM) from PEC demonstrated the presence of two specific IGFBP bands similar to those previously demonstrated in seminal plasma, with approximate mol wt of 31 and 24 kDa. The 31-kDa band was immunoprecipitable with an antibody to IGFBP-2, and neither band could be deglycosylated with endoglycosidase-F. Northern blot analysis of poly(A)+ RNA prepared from PEC with cDNAs for hIGFBP-1, -2, and -3 documented the expression of mRNA for hIGFBP-2 only. Modifications of the serum-free conditions of PEC did not significantly alter the IGFBP profile of PEC CM. The ability of IGF-I, IGF-II, and insulin to stimulate clonal growth of PEC was examined. IGF-I stimulated PEC growth with an ED50 of 0.1 ng/mL. IGF-II and insulin, respectively, were 1 and 3 orders of magnitude less effective than IGF-I in stimulating the growth of PEC. Radioimmunoassayable IGF-I and IGF-II levels in PEC CM were below the assay detection levels. In conclusion, we suggest that IGFs are important growth stimulators of PEC in culture, that their actions are mediated through the type 1 IGF receptor, and that PEC produce hIGFBP-2 and a 24-kDa IGFBP which may modulate IGF action in these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DAUGHADAY, W. H., & ROTWEIN, P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-1-68 · Cited by 1,725
Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., & Binoux, M. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90507-5 · Cited by 1,143
Insulin-Like Growth Factors as Intraovarian Regulators of Granulosa Cell Growth and Function*
ADASHI, E. Y., RESNICK, C. E., D'ERCOLE, A. J., SVOBODA, M. E., & WYK, J. J. V. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-3-400 · Cited by 911
An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.
Elgin, R. G., Busby, W. H., & Clemmons, D. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3254 · Cited by 686
Binding proteins for the insulin-like growth factors: Structure, regulation and function
Baxter, R. C., & Martin, J. L. (1989) · Progress in Growth Factor Research · doi:10.1016/0955-2235(89)90041-0 · Cited by 566
Cloning and Expression of the Growth Hormone-Dependent Insulin-Like Growth Factor-Binding Protein
Wood, W. I., Cachianes, G., Henzel, W. J., Winslow, G. A., Spencer, S. A., Hellmiss, R., Martin, J. L., & Baxter, R. C. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1176 · Cited by 364
Mohan, S., Bautista, C. M., Wergedal, J., & Baylink, D. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8338 · Cited by 356
RITVOS, O., RANTA, T., JALKANEN, J., SUIKKARI, A.-M., VOUTILAINEN, R., BOHN, H., & RUTANEN, E.-M. (1988) · Endocrinology · doi:10.1210/endo-122-5-2150 · Cited by 349
Insulinlike Growth Factor-Binding Proteins
ROSENFELD, R. G., LAMSON, G., PHAM, H., OH, Y., CONOVER, C., DE LEON, D. D., DONOVAN, S. M., OCRANT, I., & GIUDICE, L. (1990) · Proceedings of the 1989 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571146-3.50009-2 · Cited by 285
Self-citationBinkert, C., Landwehr, J., Mary, J. L., Schwander, J., & Heinrich, G. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08386.x · Cited by 241
Cited by
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Khandwala, H. M., McCutcheon, I. E., Flyvbjerg, A., & Friend, K. E. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0399 · Cited by 843
The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease*
Yousef, G. M., & Diamandis, E. P. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0424 · Cited by 675
Human prostate cancer risk factors
Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S.-M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 650
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Cohen, P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1046 · Cited by 497
Self-citationGuise, T. A., & Mundy, G. R. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0323 · Cited by 472
The Role of Liver-Derived Insulin-Like Growth Factor-I
Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J.-O., & Svensson, J. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0010 · Cited by 453
Chan, J. M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.14.1099 · Cited by 433
Stattin, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1910 · Cited by 404
Glycemic index in chronic disease: a review
Augustin, L., Franceschi, S., Jenkins, D., Kendall, C., & La Vecchia, C. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601454 · Cited by 390
Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7
Oh, Y., Nagalla, S. R., Yamanaka, Y., Kim, H.-S., Wilson, E., & Rosenfeld, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30322 · Cited by 375
Self-citationInsulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
Mantzoros, C., Tzonou, A., Signorello, L., Stampfer, M., Trichopoulos, D., & Adami, H.-O. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.520 · Cited by 366
Bubendorf, L., Kolmer, M., Kononen, J., Koivisto, P., Mousses, S., Chen, Y., Mahlamaki, E., Schraml, P., Moch, H., Willi, N., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.20.1758 · Cited by 350
Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer
Borgoño, C. A., Michael, I. P., & Diamandis, E. P. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.257.2.5 · Cited by 339
Metabolic Factors Associated with Benign Prostatic Hyperplasia
Parsons, J. K., Carter, H. B., Partin, A. W., Windham, B. G., Metter, E. J., Ferrucci, L., Landis, P., & Platz, E. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2799 · Cited by 336
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 327
Valentinis, B. (1995) · Molecular Endocrinology · doi:10.1210/me.9.3.361 · Cited by 327
Changing demography of prostate cancer in Asia
Sim, H. G., & Cheng, C. W. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.033 · Cited by 319
Aune, D., Navarro Rosenblatt, D. A., Chan, D. S., Vieira, A. R., Vieira, R., Greenwood, D. C., Vatten, L. J., & Norat, T. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.067157 · Cited by 314
Hormonal Predictors of Prostate Cancer: A Meta-Analysis
Shaneyfelt, T., Husein, R., Bubley, G., & Mantzoros, C. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.847 · Cited by 310
Regulation of prostatic growth and function by peptide growth factors
Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Hittmair, A., Zhang, J., Thurnher, M., Bartsch, G., & Klocker, H. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199606)28:6<392::aid-pros9>3.0.co;2-c · Cited by 307
Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D., & Partin, A. W. (1998) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408369891234219 · Cited by 303
The Role of the Insulin-like Growth Factor System in Human Cancer
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60354-1 · Cited by 293
Protein tyrosine kinases and cancer
Kolibaba, K. S., & Druker, B. J. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00022-x · Cited by 291
DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
The Effect of Chronic Treatment With GH on Gonadal Function in Men With Isolated GH Deficiency
Carani, C., Granata, A., De Rosa, M., Garau, C., Zarrilli, S., Paesano, L., Colao, A., Marrama, P., & Lombardi, G. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400224 · Cited by 54
Metadata
- Authors
- COHEN, P., PEEHL, D. M., LAMSON, G., & ROSENFELD, R. G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1991-08
- Volume
- 73
- Issue
- 2
- Pages
- 401-407
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2070769230
- Cited by
- 355
- References
- 17
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.